Preclinical and Clinical Researchers play a critical role in the drug development process, ensuring that new treatments are both effective and safe before they reach the market. Preclinical researchers conduct studies in laboratories and animal models to gather the initial data on a drug’s safety, efficacy, and pharmacokinetics. These early-stage studies help identify the potential risks and benefits of a drug, as well as the optimal dosage and administration routes. Preclinical research serves as the foundation for clinical trials, where drugs are tested in human subjects for the first time. Preclinical studies are essential for laying the groundwork for clinical research, ensuring that only the most promising candidates advance to human testing.
After passing preclinical testing, clinical researchers take over to lead trials in human volunteers and patients. Clinical researchers are responsible for designing and conducting clinical trials, which are divided into phases to evaluate the drug’s safety, effectiveness, and long-term impacts. Clinical researchers ensure that all trials are conducted ethically and in compliance with regulatory guidelines, gathering critical data to support drug approval by regulatory agencies. By analyzing data from clinical trials, these researchers provide vital information that helps determine whether a drug can be approved for widespread use. As the demand for more personalized and targeted therapies grows, preclinical and clinical researchers are essential in transforming scientific discoveries into real-world treatments that benefit patients globally.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico